Doranne Thomassen on Quantifying Uncertainty in Machine Learning Models
Doranne Thomassen, Postdoc researcher (Medical Statistics) at Leiden University Medical Center, shared on LinkedIn:
”New publication!
The Lancet Digital Health has published our Viewpoint on uncertainty in ML-based risk predictions in healthcare.
In this study, we developed a computational method to express individual prediction uncertainty as an effective sample size, with illustrations for logistic regression, elastic net, neural net, random forest and XGBoost.
Our findings emphasize the importance of considering prediction uncertainty at the individual level from the perspective of trustworthy AI.
Effective sample sizes can be used when evaluating the trustworthiness of predicted risks for individual patients.
Thanks to the team Saskia le Cessie, Ewout Steyerberg, Toby Hackmann Jelle Goeman, LUMC – Biomedical Data Sciences”
Read the full article in The Lancet Digital Health.
Article: Effective sample size for individual risk predictions: quantifying uncertainty in machine learning models
Authors: Doranne Thomassen, Toby Hackmann, Jelle Goeman, Ewout Steyerberg, Saskia le Cessie

Stay updated on all scientific advances with Hemostasis Today.
-
Dec 1, 2025, 11:21Margret Leosdottir on Statin–Ezetimibe Algorithm Dramatically Improving Post-MI LDL-C Outcomes
-
Dec 1, 2025, 10:46Maciej Banach: Ischemic Stroke is a Significant Global Health Challenge
-
Dec 1, 2025, 09:44Tomaz Crochemore on Clot-Phenotyping’s Role in Prevention of Irreversible Organ Damage from Fibrinolysis Shutdown
-
Dec 1, 2025, 09:24HemeBot Hosts HemeNext Conference: Yashpal Singh Rawat on Fortis Leading India’s Innovation Journey
-
Nov 30, 2025, 23:50Nita Radhakrishnan Shares The Results of Nationwide Survey on Services for Thalassemia in India
-
Nov 30, 2025, 23:37Shabhin Bhaskaran: Who Smokes 20 Cigarettes a Day is 6 Times More Likely to Have a Stroke
-
Nov 30, 2025, 19:03Safal Shetty on Building a Continuous Culture of Stroke Awareness at KIMS
-
Nov 30, 2025, 18:35Pradeep Natarajan on Milvexian and Abelacimab vs Enoxaparin to Prevent VTE Post-Arthroplasty
-
Nov 30, 2025, 13:23Ditte Vestergaard Hansen and Colleagues on Predictors of VTE Post-Stroke
